Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 271 | 351↑29.7% | 363↑3.4% | 434↑19.5% | 560↑29.0% |
| Gross Profit | 265 | 335↑26.6% | 335↓0.1% | 389↑16.1% | 484↑24.3% |
| Operating Income | -330 | -382↓15.6% | -649↓70.0% | -569↑12.3% | -536↑5.8% |
| Net Income | -187 | -454↓143.4% | -707↓55.8% | -607↑14.2% | -569↑6.2% |
| EBITDA | -140 | -410↓193.5% | -640↓56.1% | -516↑19.4% | -469↑9.2% |
| EPS Diluted | -3.07 | -6.70↓118.2% | -10.12↓51.0% | -8.25↑18.5% | -6.29↑23.8% |